\appendix
\chapter{DUD-Eデータセットの詳細}\label{appendix:dude}
DUD-E（A Database of Useful Decoys: Enhanced）はMysingerらによって作成されたドッキングシミュレーションツールを評価するための
データセットであり\cite{Mysinger2012}，無料で公開されている（\url{http://dude.docking.org/}）．
ターゲットは薬剤開発の標的となるものを多様性を考慮しながら102種類選ばれており，それぞれに対して
1. 正例化合物群，2. 負例化合物群，3. 代表タンパク質構造の3つが用意されている．

正例化合物群，負例化合物群，代表タンパク質構造はそれぞれ以下の手順で選択されている．
\begin{enumerate}
\item 正例化合物群
	\begin{enumerate}
	\item ターゲットタンパク質への実験データがある化合物をChEMBL\cite{Gaulton2012}から取得
	\item (a)の化合物のうち，タンパク質の機能の阻害性能を示す$\mathrm{IC_{50}}$（タンパク質の機能を50\%阻害する時の化合物濃度）が$\mathrm{1\mu M}$以下である化合物を既知の阻害剤とする
	\item 既知阻害剤に対しBemis-Murcko atomic frameworks（化合物の構造に基づいたクラスタリング手法\cite{Bemis1996}）を用いた
		クラスタリングを行い，化合物数が100以上になるようにN個の化合物を$\mathrm{IC_{50}}$の良い順番に各クラスタから選択する
	\end{enumerate}
\item 負例化合物群\\
	負例化合物群は以下2種類の化合物で構成されている．
	\begin{itemize}
	\item デコイ化合物（実験は行われていないが，標的タンパク質の阻害を行わないと考えられる化合物）
	\item 既知の負例化合物（実験によって	標的タンパク質の阻害をしないことが確認されている化合物）
	\end{itemize}
	デコイ化合物は1. で作成した正例化合物群のそれぞれに対して以下の操作を行うことで作成される．
	\begin{enumerate}
	\item 注目している化合物の分子量，分配係数など物理化学的な値を計算し，これと近い物性を持つ化合物を
		ZINC\cite{Irwin2005}から数千個取得する
	\item ZINCから得た数千個の化合物のうち，正例化合物群のどれかに構造が似ている化合物を除去する
	\item 残った化合物群の中から，50個をランダムサンプリングする
	\end{enumerate}
	また，実験の結果$\mathrm{IC_{50}}$が$\mathrm{30\mu M}$よりも悪い化合物を「既知の負例化合物」として負例化合物群に追加する．
\item 代表タンパク質構造
	\begin{enumerate}
	\item ターゲットタンパク質の立体構造をPDBより多数取得する
	\item (a)で得た全ての立体構造に対し，上記1. 2. の正例/負例化合物群を用いてドッキングを実施
	\item 立体構造の解像度が良く，ドッキングの結果正例/負例の弁別精度が高い，人間のタンパク質を(a)の立体構造から選択し，
		代表タンパク質構造とする
	\end{enumerate}
\end{enumerate}

\newpage

\begin{table}[t] \centering
	\caption{DUD-Eの詳細(1)}
	\label{tb:dude_description:1}
	\begin{tabular}{c|c|p{6cm}|rr|rr}
	\hline
	\multirow{2}{*}{ターゲット}	&\multirow{2}{*}{PDBID}	&\multicolumn{1}{c|}{\multirow{2}{*}{タンパク質詳細}}	&\multicolumn{2}{c|}{化合物数}	&\multicolumn{2}{c}{平均フラグメント数}		\\
							&					&											&正例	&負例				&正例	&負例						\\ \hline
aa2ar&3EML&Adenosine A2a receptor&482&31,498&6.26&7.04 \\
abl1&2HZI&Tyrosine-protein kinase ABL&182&10,746&7.08&7.33 \\
ace&3BKL&Angiotensin-converting enzyme&282&16,860&9.90&7.52 \\
aces&1E66&Acetylcholinesterase&453&26,233&9.48&8.07 \\
ada&2E1W&Adenosine deaminase&93&5,449&8.16&8.01 \\
ada17&2OI0&ADAM17&532&35,809&8.81&8.32 \\
adrb1&2VT4&Beta-1 adrenergic receptor&247&15,842&10.05&9.62 \\
adrb2&3NY8&Beta-2 adrenergic receptor&231&14,993&10.35&9.72 \\
akt1&3CQW&Serine / threonine-protein kinase AKT&293&16,426&6.94&8.00 \\
akt2&3D0E&Serine / threonine-protein kinase AKT2&117&6,893&6.61&7.39 \\
aldr&2HV5&Aldose reductase&159&8,995&4.81&5.34 \\
ampc&1L2S&Beta-lactamase&48&2,832&4.94&4.95 \\
andr&2AM9&Androgen Receptor&269&14,343&3.91&4.67 \\
aofb&1S3B&Monoamine oxidase B&122&6,900&4.37&4.39 \\
bace1&3L5D&Beta-secretase 1&283&18,080&10.72&8.79 \\
braf&3D4Q&Serine / threonine-protein kinase B-raf&152&9,942&7.27&7.24 \\
cah2&1BCD&Carbonic anhydrase II&492&31,133&7.14&7.10 \\
casp3&2CNK&Caspase-3&199&10,692&10.47&8.72 \\
cdk2&1H00&Cyclin-dependent kinase 2&474&27,830&6.25&6.70 \\
comt&3BWM&Catechol O-methyltransferase&41&3,848&4.85&5.15 \\
cp2c9&1R9O&Cytochrome P450 2C9&120&7,446&7.18&6.78 \\
cp3a4&3NXU&Cytochrome P450 3A4&170&11,796&7.71&7.42 \\
csf1r&3KRJ&Macrophage colony stimulating factor receptor&166&12,144&6.86&6.92 \\
cxcr4&3ODU&C-X-C chemokine receptor type 4&40&3,406&6.75&7.30 \\
def&1LRU&Peptide deformylase&102&5,696&9.78&7.77 \\
dhi1&3FRJ&11-beta-hydroxysteroid dehydrogenase 1&330&19,340&5.89&5.54 \\ 
dpp4&2I78&Dipeptidyl peptidase IV&533&40,916&6.52&6.44 \\
\hline
	\end{tabular}
\end{table}
\begin{table}[t] \centering
	\caption{DUD-Eの詳細(2)}
	\label{tb:dude_description:2}
	\begin{tabular}{c|c|p{6cm}|rr|rr}
	\hline
	\multirow{2}{*}{ターゲット}	&\multirow{2}{*}{PDBID}	&\multicolumn{1}{c|}{\multirow{2}{*}{タンパク質詳細}}	&\multicolumn{2}{c|}{化合物数}	&\multicolumn{2}{c}{平均フラグメント数}		\\
							&					&											&正例	&負例				&正例	&負例						\\ \hline
drd3&3PBL&Dopamine D3 receptor&480&34,022&7.58&7.30 \\
dyr&3NXO&Dihydrofolate reductase&231&17,170&6.68&7.10 \\
egfr&2RGP&Epidermal growth factor receptor erbB1&542&35,020&7.27&7.74 \\
esr1&1SJ0&Estrogen receptor alpha&383&20,663&5.55&6.72 \\
esr2&2FSZ&Estrogen receptor beta&367&20,182&5.21&6.56 \\
fa10&3KL6&Coagulation factor X&537&20,023&9.01&8.18 \\
fa7&1W7X&Coagulation factor VII&114&6,245&10.29&8.26 \\
fabp4&2NNQ&Fatty acid binding protein adipocyte&47&2,749&6.68&6.53 \\
fak1&3BZ3&Focal adhesion kinase 1&100&5,350&8.44&8.12 \\
fgfr1&3C4F&Fibroblast growth factor receptor 1&139&333&7.33&7.55 \\
fkb1a&1J4H&FK506-binding protein 1A&111&5,800&9.75&8.42 \\
fnta&3E37&Protein farnesyltransferase / geranylgeranyltransferase type I alpha subunit&592&51,430&8.20&7.65 \\
fpps&1ZW5&Farnesyl diphosphate synthase&85&8,822&7.08&7.01 \\
gcr&3BQD&Glucocorticoid receptor&258&14,987&5.33&5.94 \\
glcm&2V3F&Beta-glucocerebrosidase&54&3,799&8.57&7.93 \\
gria2&3KGC&Glutamate receptor ionotropic, AMPA 2&158&11,832&6.47&6.52 \\
grik1&1VSO&Glutamate receptor ionotropic kainate 1&101&6,547&5.83&6.32 \\
hdac2&3MAX&Histone deacetylase 2&185&10,299&10.02&8.29 \\
hdac8&3F07&Histone deacetylase 8&170&10,448&9.52&7.95 \\
hivint&3NF7&Human immunodeficiency virus type 1 integrase&100&6,644&6.42&6.35 \\
hivpr&1XL2&Human immunodeficiency virus type 1 protease&536&35,688&11.16&8.75 \\
hivrt&3LAN&Human immunodeficiency virus type 1 reverse transcriptase&338&18,879&4.98&5.65 \\
hmdh&3CCW&HMG-CoA reductase&170&8,743&9.79&8.56 \\
\hline
	\end{tabular}
\end{table}
\begin{table}[t] \centering
	\caption{DUD-Eの詳細(3)}
	\label{tb:dude_description:3}
	\begin{tabular}{c|c|p{6cm}|rr|rr}
	\hline
	\multirow{2}{*}{ターゲット}	&\multirow{2}{*}{PDBID}	&\multicolumn{1}{c|}{\multirow{2}{*}{タンパク質詳細}}	&\multicolumn{2}{c|}{化合物数}	&\multicolumn{2}{c}{平均フラグメント数}		\\
							&					&											&正例	&負例				&正例	&負例						\\ \hline
hs90a&1UYG&Heat shock protein HSP 90-alpha&88&4,848&5.56&7.20 \\
hxk4&3F9M&Hexokinase type IV&92&4,696&6.78&6.97 \\
igf1r&2OJ9&Insulin-like growth factor I receptor&148&9,291&7.95&8.27 \\
inha&2H7L&Enoyl-[acyl-carrier-protein] reductase&43&2,300&7.14&6.17 \\
ital&2ICA&Leukocyte adhesion glycoprotein LFA-1 alpha&138&8,487&7.72&7.62 \\
jak2&3LPB&Tyrosine-protein kinase JAK2&107&6,495&6.23&6.63 \\
kif11&3CJO&Kinesin-like protein 1&116&6,848&6.78&6.18 \\
kit&3G0E&Stem cell growth factor receptor&166&10,447&7.80&7.57 \\
kith&2B8T&Thymidine kinase&57&2,850&6.70&7.60 \\
kpcb&2I0E&Protein kinase C beta&135&8,692&5.67&6.85 \\
lck&2OF2&Tyrosine-protein kinase LCK&420&27,374&7.20&7.32 \\
lkha4&3CHP&Leukotriene A4 hydrolase&171&9,448&7.70&7.59 \\
mapk2&3M2W&MAP kinase-activated protein kinase 2&101&6,147&4.67&5.58 \\
mcr&2AA2&Mineralocorticoid receptor&94&5,146&5.43&5.91 \\
met&3LQ8&Hepatocyte growth factor receptor&166&11,240&7.45&7.48 \\
mk01&2OJG&MAP kinase ERK2&79&4,548&7.25&6.84 \\
mk10&2ZDT&c-Jun N-terminal kinase 3&104&6,599&6.63&6.71 \\
mk14&2QD9&MAP kinase p38 alpha&578&35,810&7.31&7.03 \\
mmp13&830C&Matrix metalloproteinase 13&572&37,126&8.98&8.29 \\
mp2k1&3EQH&Dual specificity mitogen-activated protein kinase kinase 1&121&8,147&6.92&8.02 \\
nos1&1QW6&Nitric-oxide synthase, brain&100&8,050&4.86&5.50 \\
nram&1B9V&Neuraminidase&98&6,199&8.39&7.01 \\
pa2ga&1KVO&Phospholipase A2 group IIA&99&5,146&10.12&9.63 \\
parp1&3L3M&Poly [ADP-ribose] polymerase-1&508&30,035&5.07&5.57 \\
pde5a&1UDT&Phosphodiesterase 5A&398&27,521&6.95&7.63 \\
pgh1&2OYU&Cyclooxygenase-1&195&10,797&4.66&4.72 \\
pgh2&3LN1&Cyclooxygenase-2&435&23,135&5.14&5.28 \\
plk1&2OWB&Serine / threonine-protein kinase PLK1&107&6,797&7.16&7.95 \\
\hline
	\end{tabular}
\end{table}
\begin{table}[t] \centering
	\caption{DUD-Eの詳細(4)}
	\label{tb:dude_description:4}
	\begin{tabular}{c|c|p{6cm}|rr|rr}
	\hline
	\multirow{2}{*}{ターゲット}	&\multirow{2}{*}{PDBID}	&\multicolumn{1}{c|}{\multirow{2}{*}{タンパク質詳細}}	&\multicolumn{2}{c|}{化合物数}	&\multicolumn{2}{c}{平均フラグメント数}		\\
							&					&											&正例	&負例				&正例	&負例						\\ \hline
pnph&3BGS&Purine nucleoside phosphorylase&103&6,950&3.93&6.08 \\
ppara&2P54&Peroxisome proliferator-activated receptor alpha&373&19,356&9.75&8.98 \\
ppard&2ZNP&Peroxisome proliferator-activated receptor delta&240&12,223&8.95&8.69 \\
pparg&2GTK&Peroxisome proliferator-activated receptor gamma&484&25,256&9.19&8.61 \\
prgr&3KBA&Progesterone receptor&293&15,642&3.95&4.65 \\
ptn1&2AZR&Protein-tyrosine phosphatase 1B&130&7,243&8.98&7.62 \\
pur2&1NJS&GAR transformylase&50&2,694&12.18&8.54 \\
pygm&1C8K&Muscle glycogen phosphorylase&77&3,940&6.74&6.19 \\
pyrd&1D3G&Dihydroorotate dehydrogenase&111&6,446&5.66&5.64 \\
reni&3G6Z&Renin&104&6,955&14.59&11.68 \\
rock1&2ETR&Rho-associated protein kinase 1&100&6,297&5.54&6.30 \\
rxra&1MV9&Retinoid X receptor alpha&131&6,935&5.95&5.79 \\
sahh&1LI4&Adenosylhomocysteinase&63&3,450&3.46&5.67 \\
src&3EL8&Tyrosine-protein kinase SRC&524&34,454&7.18&7.61 \\
tgfr1&3HMM&TGF-beta receptor type I&133&8,498&5.02&5.66 \\
thb&1Q4X&Thyroid hormone receptor beta-1&103&7,441&6.52&7.19 \\
thrb&1YPE&Thrombin&461&26,948&11.09&8.75 \\
try1&2AYW&Trypsin I&449&25,914&10.42&8.34 \\
tryb1&2ZEC&Tryptase beta-1&148&7,643&11.55&9.19 \\
tysy&1SYN&Thymidylate synthase&109&6,738&8.57&7.14 \\
urok&1SQT&Urokinase-type plasminogen activator&162&9,841&7.29&6.88 \\
vgfr2&2P2I&Vascular endothelial growth factor receptor 2&409&24,927&7.23&7.37 \\
wee1&3BIZ&Serine / threonine-protein kinase WEE1&102&6,148&5.87&7.57 \\
xiap&3HL5&Inhibitor of apoptosis protein 3&100&5,145&11.89&8.87 \\ \hline
	\end{tabular}
\vspace{2cm}
\end{table}

\chapter{各手法を単体で用いた場合のROC曲線}\label{appendix:roc}
\ref{subsec:single_accuracy}節にて示した
総和法（score\_sum），最良値法（score\_max），総和法と最良値法の値の線形和（maxsumBS）の3つの提案手法
およびGlide HTVSモードをそれぞれ単体で用いた場合のROC曲線を図\ref{fig:roc:1}から図\ref{fig:roc:17}に示す．
3つの提案手法についてはフラグメントの結合スコア算出をGlide SPモード / Glide HTVSモードで行った場合がそれぞれ示されている．
例えば，「score\_max\_SP」とはフラグメントの結合スコアをGlide SPモードで求め，そのフラグメントスコアの最良値をとった場合の精度が
ROC曲線で示されている．
また，ROC-AUCの値については表\ref{table:auc:1}から表\ref{table:auc:4}にも記載する．

\input{appendix_roc.tex}

\begin{table}[t] \centering
	\caption{各手法単体性能AUC-ROC値(1)}
	\label{table:auc:1}
	\begin{tabular}{c|rrrrrr|r}
	\hline
		&\multicolumn{6}{c|}{提案手法}&\multicolumn{1}{c}{簡易ドッキング} \\
ターゲット	&\multicolumn{2}{c}{score\_sum}&\multicolumn{2}{c}{score\_max}&\multicolumn{2}{c|}{maxsumBS}&\multicolumn{1}{c}{シミュレーション} \\
		&SP&HTVS&SP&HTVS&SP&HTVS&\multicolumn{1}{c}{（Glide HTVS）} \\
\hline
aa2ar&0.563&0.574&0.656&0.586&0.665&0.620&0.729 \\
abl1&0.646&0.662&0.545&0.501&0.637&0.637&0.794 \\
ace&0.471&0.485&0.458&0.478&0.446&0.457&0.611 \\
aces&0.361&0.346&0.638&0.619&0.518&0.491&0.458 \\
ada&0.581&0.549&0.706&0.670&0.738&0.698&0.734 \\
ada17&0.598&0.599&0.760&0.638&0.650&0.660&0.716 \\
adrb1&0.549&0.574&0.637&0.593&0.615&0.606&0.576 \\
adrb2&0.558&0.563&0.529&0.525&0.566&0.568&0.641 \\
akt1&0.748&0.687&0.804&0.736&0.824&0.773&0.539 \\
akt2&0.711&0.668&0.615&0.575&0.718&0.660&0.738 \\
aldr&0.503&0.510&0.798&0.787&0.719&0.714&0.675 \\
ampc&0.716&0.733&0.508&0.534&0.674&0.696&0.763 \\
andr&0.525&0.502&0.746&0.674&0.747&0.670&0.570 \\
aofb&0.553&0.552&0.590&0.588&0.614&0.601&0.657 \\
bace1&0.627&0.628&0.399&0.376&0.510&0.496&0.686 \\
braf&0.803&0.819&0.579&0.661&0.773&0.823&0.805 \\
cah2&0.653&0.647&0.441&0.426&0.555&0.545&0.494 \\
casp3&0.534&0.526&0.575&0.581&0.568&0.564&0.655 \\
cdk2&0.618&0.630&0.580&0.604&0.638&0.644&0.780 \\
comt&0.566&0.568&0.693&0.754&0.702&0.688&0.718 \\
cp2c9&0.629&0.639&0.487&0.506&0.588&0.599&0.547 \\
cp3a4&0.684&0.683&0.512&0.484&0.650&0.630&0.685 \\
csf1r&0.739&0.729&0.561&0.533&0.688&0.658&0.662 \\
cxcr4&0.691&0.674&0.778&0.759&0.770&0.760&0.872 \\
def&0.238&0.220&0.983&0.993&0.379&0.386&0.733 \\
dhi1&0.660&0.646&0.292&0.264&0.528&0.502&0.650 \\
\hline
	\end{tabular}
\end{table}
\clearpage
\begin{table}[t] \centering
	\caption{各手法単体性能AUC-ROC値(2)}
	\label{table:auc:2}
	\begin{tabular}{c|rrrrrr|r}
	\hline
		&\multicolumn{6}{c|}{提案手法}&\multicolumn{1}{c}{簡易ドッキング} \\
ターゲット	&\multicolumn{2}{c}{score\_sum}&\multicolumn{2}{c}{score\_max}&\multicolumn{2}{c|}{maxsumBS}&\multicolumn{1}{c}{シミュレーション} \\
		&SP&HTVS&SP&HTVS&SP&HTVS&\multicolumn{1}{c}{（Glide HTVS）} \\
\hline
dpp4&0.713&0.718&0.785&0.846&0.757&0.777&0.710 \\
drd3&0.502&0.478&0.515&0.464&0.522&0.491&0.608 \\
dyr&0.597&0.600&0.885&0.864&0.846&0.843&0.707 \\
egfr&0.537&0.536&0.687&0.618&0.655&0.592&0.757 \\
esr1&0.671&0.683&0.785&0.787&0.821&0.815&0.666 \\
esr2&0.646&0.633&0.797&0.793&0.820&0.810&0.759 \\
fa10&0.863&0.856&0.413&0.368&0.720&0.684&0.797 \\
fa7&0.831&0.849&0.527&0.635&0.766&0.823&0.855 \\
fabp4&0.608&0.606&0.637&0.575&0.737&0.676&0.855 \\
fak1&0.598&0.541&0.872&0.745&0.856&0.744&0.817 \\
fgfr1&0.582&0.581&0.460&0.523&0.532&0.565&0.522 \\
fkb1a&0.526&0.557&0.520&0.600&0.577&0.641&0.757 \\
fnta&0.615&0.601&0.538&0.425&0.622&0.544&0.806 \\
fpps&0.868&0.737&0.998&0.985&0.993&0.965&0.843 \\
gcr&0.572&0.549&0.770&0.687&0.780&0.680&0.528 \\
glcm&0.393&0.394&0.694&0.710&0.529&0.533&0.520 \\
gria2&0.534&0.530&0.776&0.764&0.737&0.736&0.655 \\
grik1&0.569&0.569&0.758&0.765&0.760&0.761&0.800 \\
hdac2&0.369&0.380&0.469&0.493&0.366&0.388&0.594 \\
hdac8&0.312&0.285&0.844&0.869&0.330&0.296&0.613 \\
hivint&0.536&0.538&0.623&0.615&0.611&0.595&0.807 \\
hivpr&0.719&0.714&0.508&0.431&0.658&0.617&0.737 \\
hivrt&0.416&0.398&0.777&0.725&0.682&0.647&0.638 \\
hmdh&0.666&0.682&0.511&0.620&0.604&0.672&0.833 \\
hs90a&0.297&0.282&0.435&0.371&0.301&0.257&0.761 \\
hxk4&0.748&0.716&0.518&0.472&0.671&0.620&0.624 \\
\hline
	\end{tabular}
\end{table}
\clearpage
\begin{table}[t] \centering
	\caption{各手法単体性能AUC-ROC値(3)}
	\label{table:auc:3}
	\begin{tabular}{c|rrrrrr|r}
	\hline
		&\multicolumn{6}{c|}{提案手法}&\multicolumn{1}{c}{簡易ドッキング} \\
ターゲット	&\multicolumn{2}{c}{score\_sum}&\multicolumn{2}{c}{score\_max}&\multicolumn{2}{c|}{maxsumBS}&\multicolumn{1}{c}{シミュレーション} \\
		&SP&HTVS&SP&HTVS&SP&HTVS&\multicolumn{1}{c}{（Glide HTVS）} \\
\hline
igf1r&0.866&0.872&0.668&0.711&0.849&0.872&0.777 \\
inha&0.430&0.450&0.349&0.343&0.380&0.398&0.547 \\
ital&0.741&0.756&0.485&0.530&0.706&0.748&0.529 \\
jak2&0.667&0.678&0.636&0.652&0.702&0.715&0.832 \\
kif11&0.686&0.673&0.635&0.602&0.735&0.710&0.740 \\
kit&0.654&0.664&0.644&0.655&0.688&0.688&0.530 \\
kith&0.436&0.417&0.887&0.829&0.698&0.694&0.615 \\
kpcb&0.469&0.465&0.743&0.679&0.724&0.703&0.742 \\
lck&0.674&0.673&0.663&0.619&0.733&0.699&0.754 \\
lkha4&0.623&0.645&0.304&0.351&0.483&0.553&0.879 \\
mapk2&0.620&0.565&0.872&0.755&0.812&0.740&0.849 \\
mcr&0.606&0.590&0.723&0.643&0.785&0.693&0.466 \\
met&0.692&0.692&0.671&0.571&0.738&0.669&0.818 \\
mk01&0.706&0.708&0.450&0.510&0.621&0.652&0.593 \\
mk10&0.718&0.720&0.571&0.605&0.717&0.735&0.721 \\
mk14&0.759&0.780&0.519&0.601&0.687&0.742&0.611 \\
mmp13&0.670&0.675&0.562&0.613&0.605&0.600&0.715 \\
mp2k1&0.608&0.623&0.642&0.628&0.652&0.664&0.742 \\
nos1&0.597&0.583&0.749&0.670&0.691&0.644&0.629 \\
nram&0.906&0.924&0.637&0.740&0.857&0.899&0.749 \\
pa2ga&0.585&0.576&0.649&0.669&0.656&0.652&0.652 \\
parp1&0.703&0.695&0.897&0.892&0.907&0.892&0.832 \\
pde5a&0.474&0.464&0.732&0.681&0.643&0.601&0.727 \\
pgh1&0.650&0.643&0.465&0.473&0.605&0.597&0.558 \\
pgh2&0.727&0.718&0.440&0.435&0.650&0.639&0.652 \\
plk1&0.748&0.722&0.709&0.572&0.795&0.712&0.865 \\
\hline
	\end{tabular}
\end{table}
\clearpage
\begin{table}[t] \centering
	\caption{各手法単体性能AUC-ROC値(4)}
	\label{table:auc:4}
	\begin{tabular}{c|rrrrrr|r}
	\hline
		&\multicolumn{6}{c|}{提案手法}&\multicolumn{1}{c}{簡易ドッキング} \\
ターゲット	&\multicolumn{2}{c}{score\_sum}&\multicolumn{2}{c}{score\_max}&\multicolumn{2}{c|}{maxsumBS}&\multicolumn{1}{c}{シミュレーション} \\
		&SP&HTVS&SP&HTVS&SP&HTVS&\multicolumn{1}{c}{（Glide HTVS）} \\
\hline
pnph&0.616&0.650&0.989&0.982&0.970&0.940&0.900 \\
ppara&0.667&0.642&0.462&0.483&0.593&0.585&0.633 \\
ppard&0.628&0.684&0.444&0.563&0.580&0.681&0.602 \\
pparg&0.652&0.649&0.500&0.474&0.639&0.627&0.618 \\
prgr&0.574&0.554&0.733&0.677&0.742&0.681&0.644 \\
ptn1&0.715&0.701&0.746&0.767&0.776&0.776&0.576 \\
pur2&0.788&0.756&0.986&0.906&0.985&0.896&0.927 \\
pygm&0.557&0.555&0.626&0.572&0.639&0.588&0.485 \\
pyrd&0.788&0.755&0.552&0.550&0.733&0.701&0.745 \\
reni&0.602&0.590&0.577&0.433&0.596&0.516&0.667 \\
rock1&0.749&0.739&0.803&0.805&0.849&0.835&0.768 \\
rxra&0.630&0.594&0.755&0.667&0.826&0.717&0.755 \\
sahh&0.609&0.594&0.981&0.983&0.936&0.946&0.849 \\
src&0.564&0.578&0.612&0.620&0.619&0.626&0.687 \\
tgfr1&0.774&0.798&0.408&0.540&0.675&0.763&0.850 \\
thb&0.544&0.559&0.491&0.554&0.507&0.550&0.788 \\
thrb&0.750&0.770&0.610&0.628&0.724&0.744&0.817 \\
try1&0.843&0.833&0.419&0.435&0.711&0.696&0.789 \\
tryb1&0.729&0.704&0.538&0.505&0.667&0.618&0.623 \\
tysy&0.674&0.673&0.907&0.902&0.899&0.888&0.836 \\
urok&0.819&0.820&0.470&0.491&0.719&0.733&0.677 \\
vgfr2&0.662&0.665&0.722&0.736&0.742&0.766&0.722 \\
wee1&0.446&0.394&0.990&0.962&0.923&0.802&0.933 \\
xiap&0.391&0.408&0.378&0.451&0.342&0.366&0.802 \\
\hline
\multicolumn{8}{c}{\ } \\
\multicolumn{8}{c}{\ } \\
	\end{tabular}
\end{table}